Topic summary

How compounding permissions changed when supply normalised

Sourcing › Regulatory personal import EMA compounding research use only Solved

This is a generated summary. It shows the 5 most-liked posts from a topic of 35, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

me.eriksenTL2 Moderator29 Dec 2024#4

c.correia, post #3: post #2 is right about the mechanism and I think understates the practical bit. Primary documents matter: regulatory positions are published in official documents. Reading the regulatory agency's website directly is more reliable than reading a forum summary of it. Go to post

Worth separating two things that the opening post runs together.

Regulatory positions change: a compound's status today might differ from its status a year from now. Citing a regulatory position is worth doing only with a date attached.

21 likes in reply to #3 19mo

m.perrinTL2 Moderator Solution2 Jan 2025#5

Picking up post #2: that is the part I would want checked first.

Labelling and intended use: a compound sold as "research-use-only" does not change its pharmacology if ingested. It changes the legal status of the sale. The labelling tells you the intended use, not the actual use people make of it.

7 likes 19mo

dr_okonkwoTL4 Moderator12 Jan 2025#8

s.karlsen_rph, post #6: Off-label use and medical practice: clinicians can prescribe approved medications off-label under some circumstances. That is different from research-use-only compounds, which are not approved for any human use. Go to post

Staff post. Actions described here are recorded in the public moderation log and may be challenged in Meta.

On post #4 — agreed on the reasoning, with one qualification.

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

29 likes in reply to #6 18mo

KStephanopoulosTL3Regular6 Feb 2025#16

30 likes 18mo

t.ibarraTL2 Moderator9 Mar 2025#28

Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The regulatory position reflects this asymmetry.

28 likes 17mo

Read the full topic (35 posts)

This topic was referenced in

Why a compound being unapproved is not the same as being illegal to possessSourcing › Regulatory · 78 replies

Suggested topics

Topic	Participants	Replies	Views	Activity
Research-use-only labelling: what it means and what it does not Sourcing › Regulatory compounding research use only EMA FDA Posting this under the heading it deserves: Research-use-only labelling: what it means and what it does not Everything below is what sits behind that. I would like to talk about documentation quality as a…	+100	110	37k	5mo
Reading a regulatory notice rather than an article about it Sourcing › Regulatory compounding personal import EMA Posting this under the heading it deserves: Reading a regulatory notice rather than an article about it Everything below is what sits behind that. Structured report rather than an opinion, following the…		2	2.9k	5mo
Coming back to: Research-use-only labelling: what it means and what it does not Sourcing › Regulatory MHRA personal import research use only Solved Research-use-only labelling: what it means and what it does not — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…	+45	50	39k	20mo
Pharmaceutical compounding rules, summarised from primary sources Sourcing › Regulatory MHRA EMA research use only Closed Pharmaceutical compounding rules, summarised from primary sources — setting out what I have, and where I think it stops being reliable. Structured report rather than an opinion, following the format the…	+135	163	46k	17mo
Why a compound being unapproved is not the same as being illegal to possess Sourcing › Regulatory FDA MHRA research use only EMA Why a compound being unapproved is not the same as being illegal to possess I have a specific reason for asking rather than idle curiosity, and the context is below. Structured report rather than an opinion,…	+72	78	23k	3mo

Related topics — sharing the tags personal import, EMA, compounding

Topic	Participants	Replies	Views	Activity
Naming conventions for research peptides and the confusion they cause Compounds › Other compounds custom synthesis mislabelling research use only needs a source Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. Comparing STEP 8 ( JAMA , 2022) with STEP 1 ( N…	+21	25	4.9k	22d
Coming back to: Cost per delivered dose, which is the number that matters Access › Pricing formulary data table compounding cost per milligram Under review On the subject in the title: Cost per delivered dose, which is the number that matters Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…	+6	10	2.5k	19mo
Official shortage notices and what they authorise Access › Shortages compounding formulary shortage Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this…	+106	119	18k	1mo
What a regulator's shortage notice actually authorises — what changed since Sourcing › Regulatory research use only EMA FDA compounding Solved The question in the title: What a regulator's shortage notice actually authorises — what changed since I will give what I have already checked below so nobody repeats it. A logistics question, since the…	+22	26	53k	7mo
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Access › Pricing compounding formulary cost per milligram Solved Price changes over 2025 and 2026, tabulated and dated — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated,…	+147	156	18k	3mo